Anumana

Decision/Risk Analysis · Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. Anumana is based in Cambridge, MA and was founded in 2021. It was valued at $580 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $185 million across 3 recorded rounds; the latest was a $95.4 million early-stage round in Mar 2025.

PMV mark · valuation
$580.0M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$185.3M
Last round
Early Stage VC
Mar 2025
What is Anumana worth?
$580.0MPrivateMarketView mark · Oct 2026

Valued at $580.0M at its early-stage round, Mar 2025. Nothing has traded since.

Free account
More of Anumana with a free account
  • ·Watch Anumana: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Anumana funding history

3 rounds
DateRoundRaisedPost-money
Mar 2025Early Stage VC$95.4M▮
Nov 2022Early Stage VC$32.0M▮
Apr 2021Early Stage VC (Series A)$25.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Anumana valuation

Anumana was valued at $580 million at its early-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Anumana raised?

Anumana has raised $185 million across 3 recorded rounds since 2021. The largest was a $95.4 million early-stage round in Mar 2025.

Anumana has filed 1 Form D with the SEC, most recently in Nov 2022 ($32 million sold to 72 investors).

Comparable companies

Comparable decision/risk analysis names by valuation on PrivateMarketView: Freenome ($2.2 billion), HeartFlow (NAS: HTFL) ($1.5 billion) and VideaHealth ($400 million).

How Anumana's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Anumana, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Anumana

What is Anumana worth?
Anumana is valued at $580.0M as of Oct 2026. Valued at $580.0M at its early-stage round, Mar 2025. Nothing has traded since.
How much has Anumana raised?
Anumana has raised $185.3M in total funding across 3 recorded rounds.
When did Anumana last raise?
Anumana last raised in Mar 2025 (Early Stage VC), raising $95.4M.